亚博篮球怎么下串 Sanofi-Aventis To Buy Genzyme For $19B France’s Sanofi-Aventis will acquire U.S. biotechnology company, Genzyme. February 16, 2011
亚博篮球怎么下串 Sanofi-Aventis To Raise $7B In Debt Sale Sanofi-Aventis is seeking to raise about $7 billion in a debt offering. March 24, 2011
亚博篮球怎么下串 Sanofi Extends $18.5B Genzyme Bid Sanofi-Aventis has extended it offer for the takeover of Genzyme. January 25, 2011
亚博篮球怎么下串 Sanofi, Genzyme In New Deal Talks Sanofi-Aventis is in talks with Genzyme about possibly using contingent value rights to boost its current offer for the biopharmaceutical company. January 10, 2011
This content is from:Premium SAC, Carlson Veteran Karp Has Standout Year with Tourbillon Jason Karp’s firm has grown its long-short fund’s assets exponentially on the back of strong performance since its 2013 launch. ByStephen Taub January 12, 2016
This content is from:365亚博 Will Sanofi-Genzyme Deal Usher In Other Big Pharmaceutical Mergers? As big pharmaceuticals need to replace their revenues with new unique products, biopharmaceuticals such as Genzyme, are the ideal solution. ByUdayan Gupta March 04, 2011
